RESULTS FOR THE YEAR ENDED 31 MARCH 2015
Transcription
RESULTS FOR THE YEAR ENDED 31 MARCH 2015
RESULTS FOR THE YEAR ENDED 31 MARCH 2015 INTRODUCTION Graham Roberts Results for the Year Ended 31 March 2015 2 THREE YEAR PROGRESS Scale 2015 Rent roll up 59% £56m Investment property up 72% £925m Net assets up 141% £452m Flexibility 2012 2015 Free cash/available facilities £12m £125m − £147m 64% 48% Unencumbered assets LTV Performance 2015 EPS1 up 40% 2.1p NAV1 per share up 24% 44.9p Dividends up 48% 1.85p 1EPRA basis (appendix 5) Results for the Year Ended 31 March 2015 3 TRANSFORMATIONAL YEAR 46% underlying profit growth £245m of medical centre additions Portfolio now £925m (up 41%) Leverage reduced from 62% to 48% Equity raise of £175m (net) £105m invested in medical centres £57m of debt redeemed Joined EPRA/NAREIT index New UK plc holding company Quarterly dividend increased 11% in November 2 pence per share, annual basis Fully covered Results for the Year Ended 31 March 2015 4 FINANCIAL RESULTS Jonathan Murphy Results for the Year Ended 31 March 2015 5 FINANCIAL HIGHLIGHTS Income statement 2015) 2014) % change) Net rental income (£m) 48.2) 37.8) 28) Underlying profit before tax (£m) 15.9) 10.9) 46) 2.1) 2.1) -) 31 March 2015) 31 March 2014) % change) 925.3) 656.7) 41) EPRA NAV (pence per share) 44.9) 43.4) 3.4) LTV (%) 48.3) 62.0) (22) Returns 2015) 2014) % change) Dividend per share (p) 1.85) 1.36) 36) Total Property Return (%) 7.8) 7.9) (1) Total Accounting Return (%) 7.7) 15.9) (52) Underlying profit per share (p) Balance sheet Investment property (£m) Results for the Year Ended 31 March 2015 6 33% GROWTH IN ANNUALISED RENT ROLL 14.4 years weighted average unexpired lease term, 87% NHS funded £m 60 12.5 55 50 45 0.1 55.6 (0.1) 40 35 1.3 41.8 30 Mar-14 Disposals Results for the Year Ended 31 March 2015 Lease events Completed developments Acquisitions Mar-15 7 46% GROWTH IN UNDERLYING PROFIT Operational efficiency and scale benefits have enabled profit growth ahead of income growth £m 18 10.4 16 14 12 10 8 6 15.9 10.9 (4.7) Mar-14 Net finance costs (0.7) 4 2 0 Results for the Year Ended 31 March 2015 Admin expenses Net rental income Mar-15 8 EPRA NAV PER SHARE MOVEMENT 46p 2.8p 45p 44p 43p 0.1p 2.1p 42p 1.4p 41p 40p 44.9p 43.4p 1.9p 39p 38p 37p Mar-14 Other Results for the Year Ended 31 March 2015 Share issue Dividends Income (underlying profit) Capital (revaluations) Mar-15 9 41% INCREASE IN INVESTMENT PROPERTY 2015 2014 Net initial yield 5.56% 5.98% Equivalent yield 5.77% 6.07% £m 1,000 231.0 900 800 2.2 700 14.0 21.4 600 500 925.3 400 300 656.7 200 100 0 Mar-14 Other Results for the Year Ended 31 March 2015 Development costs Revaluation gain Acquisitions Mar-15 10 STRONG AND GROWING BALANCE SHEET £269m increase in investment property Property and debt Loan to value of 48% within our target range of 45% to 55% £m 1000 £125m of available facilities and cash Positioned strongly for future growth Investment property 900 Net debt 925.3 800 700 656.7 600 500 557.3 400 414.8 450.0 359.5 300 200 100 0 Mar-13 Results for the Year Ended 31 March 2015 Mar-14 Mar-15 11 FINANCING Significant refinancing completed since fund raise in October £57m facility with Santander redeemed £177m of Aviva facilities restructured resulting in 42bps reduction in rates on these loans New revolving credit facility secured from three lenders: £60m facility 170bps initial margin variable rate five year term Results for the Year Ended 31 March 2015 12 HEALTHY FINANCING RATIOS 31 March 2015 31 March 2014 Net debt (£m) 450.0 414.8 Loan to value 48% 62% Cash/undrawn facilities (£m) 95.3 27.6 5.28% 5.28% 11.9 years 10.9 years Interest cover 160% 150% % of debt at fixed rates 100% 98% Weighted average interest rate Weighted average debt maturity Results for the Year Ended 31 March 2015 13 GROWTH AND SCALE BENEFITS Increased scale has delivered cost efficiencies Track record since March 2013: EPRA Cost Ratio has fallen from 23% to 18% Costs as a % of average asset value have fallen from 0.89% to 0.72% 115% growth in dividends paid Dividends and costs p Dividends paid (left axis) 2.4 EPRA Cost Ratio (right axis) 24.0% 2.0 22.0% 1.85 1.6 20.0% 1.36 1.2 18.0% Progressive, covered dividend policy 0.8 16.0% 0.86 0.4 14.0% 0 12.0% Mar-13 Results for the Year Ended 31 March 2015 Mar-14 Mar-15 14 PROPERTY UPDATE Andrew Darke Results for the Year Ended 31 March 2015 15 SUBSTANTIAL GROWTH IN YEAR £269m increase in portfolio value £245m additions Investment property 5.6% average yield on cost Rent roll Weighted average unexpired lease term of 17 years on new additions WAULT March 2015 March 2014 £925.3m £656.7m £55.6m £41.8m 14.4 years 14.4 years Consideration Timing £107m Jun 2014 Acquisitions have refinancing and asset enhancement opportunities MP Realty Solicitors instructed on a further £40m of acquisitions One Life £12m Jul 2014 Metro £63m Nov 2014 South Kirkby £10m Dec 2014 Other £39m Various Developments £14m Various 2.4 million patients registered with our GP tenants in 265 properties Property additions Results for the Year Ended 31 March 2015 £245m 16 DEVELOPMENTS COMPLETED DURING YEAR Achieved in excess of 100 bps margin over revaluation yield on completed developments In-house experienced development team Completed Number of schemes Development cost ERV Margin over revaluation yield 4 £19.6m £1.4m >100 bps Sudbury Results for the Year Ended 31 March 2015 17 FUTURE DEVELOPMENT SCHEMES Long term requirement for country to invest in new medical centres Future pipeline of £35m – preferred developer status Number of schemes Following NHS reorganisation in April 2013, NHS England is now starting to approve developments ERV Results for the Year Ended 31 March 2015 Development cost On-site Immediate pipeline 5 9 £22.2m £25m £1.2m Sutton 18 APPROACH TO DESIGN Securing approval on new schemes – one of many benefits of in-house development Unique and bespoke Site influences Inside-out approach Sense of wellbeing Natural surveillance Environmental Sustainability Results for the Year Ended 31 March 2015 19 RENT REVIEW GROWTH RPI and fixed are currently the main drivers of rental growth 3 year rent review settlements 1.0 0.9 open market +0.38% 0.8 Land and construction cost inflation returning Less rental evidence for rent reviews due to recent hiatus in NHS approval process Absolute rent roll increase (£m) RPI and fixed +3.06% 0.38% 0.7 0.35% 0.6 3.06% 0.5 0.4 4.52% 0.3 1.99% 0.2 0.1 3.23% 0.0 RPI/fixed/other (25% of rent roll) 2012/13 Results for the Year Ended 31 March 2015 OMR (75% of rent roll) 2013/14 2014/15 20 MARKET AND OUTLOOK Graham Roberts Results for the Year Ended 31 March 2015 21 MARKET OVERVIEW Medical centre returns exhibit lower volatility than commercial property and Gilts Healthy premium over equivalent maturity Gilt >360bps Low point for rental growth RPI forecast to recover open market reviews to reflect construction recovery Yield development 8% 7% 6% 5% 4% 3% 2% IPD monthly UK index initial yield 1% Assura Net Initial Yield 15 year Gilt Results for the Year Ended 31 March 2015 0% 22 HEALTH SECTOR OUTLOOK Cross party support for primary care investment continues Election result favourable from a timing perspective leadership already understands the primary care problem has already committed funding to back new premises backed the NHS leadership Five Year Forward View Pace of acceleration in development approvals hinges on CCGs engagement Assura has received its first approval under new regime “A vision of a modern NHS working for you 7 days of the week – when you need it, where you need it. And that begins with a transformation of primary care” David Cameron 18 May 2015 There will remain a time lag between approval and delivery, typically 18 months to 2 years Results for the Year Ended 31 March 2015 23 OUTLOOK FOR ASSURA Attractive long term opportunity Assura well placed skills, structure, scale brand recognition with GPs Our three priorities are: delivering growth capturing further asset management opportunities maintaining low cost base Delivering a secure and growing dividend Results for the Year Ended 31 March 2015 24 Q&A Blaenavon Birkenhead Huthwaite Results for the Year Ended 31 March 2015 25 SUPPLEMENTARY INFORMATION 1. Market 2. Portfolio 3. Cash flows 1.1 Growing demand / inadequate supply 1.2 Market: policy direction supportive 1.3 Recent encouraging statements 1.4 Sector attractiveness 1.5 Risk reward profile unchanged 1.6 Assura well placed to outperform 2.1 Total property assets 2.2 Portfolio 2.3 Sensitivity analysis 2.4 MP Realty portfolio - £107m 2.5 One Life - £12.3m 2.6 Metro portfolio - £63.1m 2.7 South Kirkby - £10.1m 3.1 Cash flow summary 3.2 Contracted rental income 3.3 Lease lengths 3.4 Debt repayment profile Results for the Year Ended 31 March 2015 4. Rents 4.1 ERV evolution and reversion 4.2 Open market rents still increasing 4.3 Basis of rent reviews 4.4 Rent review timing 5. Net assets 5.1 EPRA net asset value 5.2 EPRA net asset value movement 5.3 Underlying & EPRA earnings per share 5.4 EPRA Cost Ratios 5.5 VCP dilution 6. REITs 6.1 REITs 7. Borrowings 7.1 Bank and bond facilities 7.2 Covenants 8. Dividends 8.1 Dividend calendar 26 1.1 GROWING DEMAND / INADEQUATE SUPPLY Demand Supply 10 year track record of cross-party support for: 2014 BMA survey of GP practices greater patient choice 40% of GPs stated premises inadequate for provision of general practice services more community based facilities (medical centres, polyclinics) 70% said premises not suitable for offering a full range of services more services delivered locally Unaffordable healthcare budget doubled in 10 years to £120bn Number of consultations with GPs has been increasing at 2.5% per annum over 340 million visits per year Results for the Year Ended 31 March 2015 80% said premises prevented them hosting a full primary / community healthcare 40% said existing premises could not be extended or developed to meet current or future needs 27 1.2 MARKET: POLICY DIRECTION SUPPORTIVE Cross-party Government support to shift heath provision from expensive acute / secondary sector into primary care setting 2014 NHS England Five Year Forward view reinforces this shift Health & Social Care Act brings GPs into commissioning role Jeremy Hunt, December 2014: “£1 billion of funding over 4 years for investment in new primary care infrastructure” Pressures mounting from changing demands ageing population different expectations of service growing range of medical solutions increasing demand changing career and practice profile Efficiency will be essential £350m Prime Minister’s challenge fund to increase access Results for the Year Ended 31 March 2015 28 1.3 RECENT ENCOURAGING STATEMENTS Five Year Forward View Better Health for London Simon Stevens, NHS Chief Executive Commission for London (Lord Darzi) Published 23 October 2014 Published 15 October 2014 Radical upgrade in prevention and public health Professionals deserve modern GP practices; patients deserve to be seen in them We need a ‘new deal’ for GPs [A future that] no longer sees expertise locked into often out-dated buildings Out-of-hospital care needs to become a much larger part of what the NHS does The NHS will invest more in primary care Results for the Year Ended 31 March 2015 The quality of facilities impacts the quality of care, and London is letting both its patients and its health professionals down Many of these new or refurbished facilities should be co-located with other services, including diagnostics, specialist care, and social care, perhaps through a ‘hub and spoke’ model 29 1.4 SECTOR ATTRACTIVENESS Market features health spend is non-discretionary planning environment ‘benign’ District Valuer determines rent reviews Tenant features private businesses underwritten by Government premises are bespoke GPs are not mobile – “stickiness” offsetting Residual Value (RV) Typical lease features 21 years, no breaks upward and downward not less than initial landlord triggers the review (3 years) often internal repairing and insuring Results for the Year Ended 31 March 2015 30 1.5 RISK REWARD PROFILE UNCHANGED Eight year total return vs standard deviation 9% 8% 7% 5% 4% 3% Total Return Since 2007 6% 2% 1% 0% 18 16 14 12 10 8 6 4 2 0 Risk (standard deviation) Source: IPD Results for the Year Ended 31 March 2015 31 1.6 ASSURA WELL PLACED TO OUTPERFORM Good reputation and relationships with GP community IPD Annual Return to Dec-14 since inception of index in 2006 Development capability and strong pipeline 8% Internally managed 7% Knowledgeable and focused team 6% Assura Primary Healthcare Benchmark 7.6% 7.0% 6.1% 6.2% 5% 4% 3% 2% 1.4% 0.8% 1% 0% Income Return Results for the Year Ended 31 March 2015 Capital Growth Total Return 32 2.1 TOTAL PROPERTY ASSETS March 15 £m March 14 £m 908.3 631.6 Investment property under construction 6.7 14.8 Properties held for sale 5.4 11.6 Pharmacy lease premiums 7.3 7.2 Finance leases 3.0 3.1 930.7 668.3 March 15 £m March 14 £m 925.3 656.7 5.4 11.6 930.7 668.3 Investment portfolio Total Balance sheet classification Investment portfolio Property assets held for sale Total Results for the Year Ended 31 March 2015 33 2.2 PORTFOLIO <£1m £1-5m £5-10m >£10m North South Midlands Scotland Wales GPs NHS Body Pharmacy Other Results for the Year Ended 31 March 2015 Properties Value (£m) Value (%) 37 180 36 12 265 25.2 451.6 253.3 178.2 908.3 2.8 49.7 27.9 19.6 Properties Value (£m) Value (%) 109 74 55 9 18 265 411.2 221.4 201.2 23.9 50.6 908.3 45.3 24.4 22.1 2.6 5.6 Rent roll (£m) Value (%) 38.1 10.2 4.3 3.0 55.6 68.5 18.4 7.7 5.4 34 2.3 SENSITIVITY ANALYSIS ERV) +1%) +2%) +3%) p/share) p/share) ) p/share) p/share) 6.00% (6.61p) (5.78p) (4.94p) (4.11p) 5.75% (2.98p) (2.11p) (1.24p) (0.36p) 5.50% 0.98p) 1.90p) 2.81p) 3.72p) 5.25% 5.33p) 6.28p) 7.24p) 8.19p) 5.00% 10.10p) 11.11p) 12.11p) 13.11p) NIY Results for the Year Ended 31 March 2015 35 2.4 MP REALTY PORTFOLIO – £107M £107m portfolio of 28 medical centres acquired in June 2014 Birmingham 5.8% yield on cost1 off-market transaction 15 years’ WAULT 90% of income from GPs / NHS bodies Potential ERV of £6.6m £0.1m of additional rent is achievable if rents brought up to current market levels £0.3m would arise on letting expansion space incremental annual overhead of £0.1m Further asset enhancement opportunities in portfolio 1 Worcester Once historical rent reviews settled Results for the Year Ended 31 March 2015 36 2.5 ONE LIFE – £12.3m £12.3m One Life building, Middlesbrough acquired in July 2014 6.5% yield on cost off-market transaction 14 years’ WAULT 92% of income from GPs / NHS bodies Rent roll Multi-discipline care providers GP practice pharmacy day case theatre x-ray and diagnostic services out-patient and community service providers Results for the Year Ended 31 March 2015 37 2.6 METRO PORTFOLIO – £63.1m £63.1m portfolio of 11 medical centres acquired in November 2014 Barry 5.4% yield on cost off-market transaction 20 years’ WAULT 89% of income from GPs / NHS bodies Potential ERV of £4.1m £0.1m of additional rent is achievable if rents brought up to current market levels £0.6m would arise on letting expansion space incremental annual overhead of £0.1m Porth Results for the Year Ended 31 March 2015 38 2.7 SOUTH KIRKBY – £10.1m £10.1m Church View Medical Centre, South Kirkby acquired in December 2014 5.2% yield on cost off-market transaction 23.5 years’ WAULT 90% of income from GPs / NHS bodies Rent roll £0.53m Multi-discipline care providers GP practice pharmacy optician community based services including maternity, diabetes screening and minor surgery Results for the Year Ended 31 March 2015 39 3.1 CASH FLOW SUMMARY March 15) £m) March 14) £m) Opening cash 38.6) 35.7) Net cash from operations 16.9) 7.9) Property and business acquisitions (64.3) (9.1) Development expenditure (14.0) (23.5) 4.2) 3.3) -) 27.4) 0.1) -) Equity issues, net of costs 173.5) -) Dividends paid (14.4) (7.2) Net borrowings movement (74.1) 4.1) 66.5) 38.6) Cash flows from investing activities: Sale of properties Sale of businesses Other Cash flows from financing activities: Closing cash Results for the Year Ended 31 March 2015 40 3.2 CONTRACTED RENTAL INCOME £853m total contracted cash flow, 93% of rent roll still contracted in 2025 60 Contracted at 31-Mar-15 50 40 30 20 10 0 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Results for the Year Ended 31 March 2015 Mar-21 Mar-22 Mar-23 Mar-24 Mar-25 Mar-26 Mar-27 Mar-28 Mar-29 Mar-30 41 3.3 LEASE LENGTHS 16 Weighted average unexpired lease term 14.4 years 142 leases 14 106 leases Rental value (£m) 12 125 leases 10 8 6 4 66 leases 51 leases 34 leases 2 0 21+ 18-20 Results for the Year Ended 31 March 2015 15-17 12-14 9-11 Years remaining 6-8 21 leases 43 leases 3-5 0-2 42 3.4 DEBT REPAYMENT PROFILE Gross debt Weighted average maturity Weighted average cost of debt March 15 March 14 £516.6m £451.9m 11.9 years 10.9 years 5.28% 5.28% 140 Aviva Bond RCF 120 100 80 60 40 20 0 Results for the Year Ended 31 March 2015 43 4.1 ERV EVOLUTION AND REVERSION ERV at Mar 15 £57.9m; vacant space £1.87m, valuers rental ERV £0.45m 60 Passing rent ERV £2.3m £55.6m 50 Rental value (£m) 40 30 20 10 0 Mar-08 Mar-09 Results for the Year Ended 31 March 2015 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 44 4.2 OPEN MARKET RENTS STILL INCREASING 1.27% annualised increase from rent reviews settled in the period 0.38% from open market rent reviews 3.06% from RPI and fixed uplift reviews Annualised Rent reviews settled in year to 31 March 2015 Number of outstanding reviews (passing rent) 0.38% Relating to review dates from calendar years: 2009 1 (£0.1m) 2010 (1 review) 1.62% 1 (£0.5m) 2011 (7 reviews) 0.59% 5 (£0.8m) 2012 (8 reviews) 0.26% 16 (£2.2m) 2013 (21 reviews) 0.30% 24 (£2.6m) 2014 (38 reviews) 0.23% 47 (£6.1m) - 127 (£15.1m) 2015 Results for the Year Ended 31 March 2015 Open market reviews only % 45 4.3 BASIS OF RENT REVIEWS 80% Upward only review basis (68%) Upward/downward review basis - landlord only trigger (26%) 70% Upward/downward review basis - tenant can instigate (6%) Proportion of rent roll 60% 50% 40% 30% 20% 10% 0% OMR Results for the Year Ended 31 March 2015 RPI Fixed Other 46 4.4 RENT REVIEW TIMING Split of current rent roll by rent review basis and frequency of review: Annually 3 Year 5 Year Other - 68% 7% - 75% 6% 5% 3% - 14% Fixed - 6% - - 6% Other - 4% - 1% 5% 6% 83% 10% 1% 100% OMR RPI Results for the Year Ended 31 March 2015 47 5.1 EPRA NET ASSET VALUE Net assets Own shares held Derivative financial instruments Deferred tax NAV in accordance with EPRA Number of shares in issue EPRA NAV per share – basic Diluted number of shares EPRA NAV per share – diluted Results for the Year Ended 31 March 2015 Adjusted (EPRA)) net asset value) Adjusted (EPRA)) net asset value) March 15) £m) March 14) £m) 451.9) 226.6) 1.8) 1.9) -) 1.8) (1.3) (0.7) 452.4) 229.6) 1,006,900,141 529,548,924 44.9p 43.4p 1,027,623,913 529,548,924 44.0p 43.4p 48 5.2 EPRA NET ASSET VALUE MOVEMENT £m) Pence per share1) 229.6) 43.4) Income (underlying profit) 15.9) 2.1) Capital (revaluations and capital gains) 21.3) 2.8) Dividends (14.4) (1.9) Share issue 201.8) (1.4) (1.8) (0.1) 452.4) 44.9) NAV in accordance with EPRA at 31 March 2014 Other NAV in accordance with EPRA at 31 March 2015 Growth 1.5p) 3.4% 1 Based on shares in issue (529,548,924 at Mar 14, 1,006,900,141 at Mar 15) or weighted average in issue over the year to Mar 15 (763,163,756) Results for the Year Ended 31 March 2015 49 5.3 UNDERLYING & EPRA EARNINGS PER SHARE 2015 £m 2014 £m Profit for the year (continuing operations) 37.2 23.8 EPRA earnings 15.8 9.2 Underlying profit 15.9 10.9 763,163,756 529,548,924 – continuing 4.9p 4.5p – EPRA 2.1p 1.7p – underlying 2.1p 2.1p 783,887,528 529,548,924 4.7p 4.5p – EPRA 2.0p 1.7p – underlying 2.0p 2.1p Weighted average number of shares in issue – basic Basic EPS Weighted average number of shares in issue – diluted Diluted EPS – continuing Results for the Year Ended 31 March 2015 50 5.4 EPRA COST RATIOS EPRA Cost Ratios give an indication of administrative and operating costs relative to gross rental income 2015 2014 EPRA Cost Ratio (including direct vacancy costs) 17.7% 20.2% EPRA Cost Ratio (excluding direct vacancy costs) 16.3% 18.4% Results for the Year Ended 31 March 2015 51 5.5 VCP DILUTION Five year scheme to align incentives for staff and management with long-term shareholder performance Participants receive 10% of total shareholder return over 8% compound hurdle rate subject to overall cap of 25 million shares (which represents 2.5% of total issued share capital) Scheme runs from 2012 – 2017 First measurement point in 2015 estimates 24.4 million shares would vest over the 5 year period of which 20.7 million would be new dilutive shares and 3.7 million would be released by the Employee Benefit Trust 50% of awarded shares held over to future periods subject to future performance Results for the Year Ended 31 March 2015 52 6.1 REITS REIT status is a tax election available to listed real estate companies REITs are tax exempt on property rental income and capital gains Profits are passed through to investors through minimum Property Income Distributions (PIDs) 90% of taxable property rental profits Subject to 20% withholding tax (unless investor is a qualifying institution) Other dividends are not subject to withholding tax Assura currently pays dividends not PIDs as the minimum PID is £nil REITs are a recognised global investment class, attractive to specialist investors REITs are required to meet rules ensuring they remain focused on real estate investment activity Development activity is permitted but taxable if developments are sold within 3 years of practical completion Results for the Year Ended 31 March 2015 53 7.1 BANK AND BOND FACILITIES Maturity Effective1 interest1 rate1 Secured properties £m Rental income £m Outstanding) 31 March) £m) Fixed 10 year, bullet repayment 2021 4.75%1 169.5 11.4 110.0) Fixed Amortising to 2044 5.43%1 592.1 35.4 406.6) Floating Five year, 2020 2.17%1 - - -) Unsecured properties 146.7 8.8 Principal 908.3 55.6 Fixed / Floating 10 year secured Bond Aviva amortising secured loans Loan / Bond £60m revolving credit facility Loan issue costs Book value 1 516.6) (3.1) 513.5) 1.70% above LIBOR, subject to LTV and interest rate swaps Results for the Year Ended 31 March 2015 54 7.2 COVENANTS All covenant conditions complied with Bond Aviva RCF Req. Act. Req. Act. Req. Act. Income v interest cover >1.5 2.09 ≥1.05 1.31 ≥1.75 n/a Loan to Value >1.35 1.52 n/a n/a <65%1 n/a In addition, bond requires NHS backed income to exceed 75% (31 March 2015: 78%) and the weighted average lease length must exceed 10 years (31 March 2015: 12.7 years) The RCF requires weighted average lease length to not at any time be less than 9 years (31 March: n/a) 1 Reduces to 60% in year 4 and 55% in year 5 Results for the Year Ended 31 March 2015 55 8.1 DIVIDEND CALENDAR Payment date Ex-div date Record date Total2 Q1 23 Apr 2014 9 Apr 2014 11 Apr 2014 0.45p2 Q2 23 Jul 2014 9 Jul 2014 11 Jul 2014 0.45p2 Q3 5 Nov 2014 23 Oct 2014 24 Oct 2014 0.45p2 Q4 21 Jan 2015 8 Jan 2015 9 Jan 2015 0.5p2 Payment date Ex-div date Record date Total2 Q1 30 Apr 2015 16 Apr 2015 17 Apr 2015 0.5p2 Q2 22 Jul 20151 9 Jul 20151 10 Jul 20151 0.5p2 Q3 21 Oct 20151 8 Oct 20151 10 Oct 20151 0.5p2 Q4 20 Jan 20161 7 Jan 20161 8 Jan 20161 0.5p2 2014/15 2015/16 1 Provisional date 2 Provisional amount Results for the Year Ended 31 March 2015 56 DISCLAIMER This presentation contains certain statements that are neither financial results nor other historical information. These statements are forward-looking in nature and are subject to risks and uncertainties. Actual future results may differ materially from those expressed in or implied by these statements. Many of these risks and uncertainties relate to factors that are beyond Assura’s ability to control or estimate precisely, such as future market conditions, the behaviour of other market participants, the actions of governmental regulators and other risk factors such as the Company’s ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Assura does not undertake any obligation to publicly release any revision to these forward-looking statements to reflect events or circumstances after the date of these materials. Information contained in this presentation relating to the Company or its share price, or the yield on its shares, should not be relied upon as a guide to future performance. Results for the Year Ended 31 March 2015 57